Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Bacillus subtilis | 4'-phosphopantetheinyl transferase ffp | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Entamoeba histolytica | hypothetical protein | 4'-phosphopantetheinyl transferase ffp | 224 aa | 198 aa | 28.3 % |
Trichomonas vaginalis | conserved hypothetical protein | 4'-phosphopantetheinyl transferase ffp | 224 aa | 197 aa | 22.3 % |
Onchocerca volvulus | 4'-phosphopantetheinyl transferase ffp | 224 aa | 186 aa | 26.3 % | |
Candida albicans | aminoadipate-semialdehyde dehydrogenase small subunit | 4'-phosphopantetheinyl transferase ffp | 224 aa | 183 aa | 27.3 % |
Candida albicans | aminoadipate-semialdehyde dehydrogenase small subunit | 4'-phosphopantetheinyl transferase ffp | 224 aa | 183 aa | 27.3 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0883 | 1 | 1 |
Trypanosoma cruzi | cytochrome P450, putative | 0.0119 | 0.0379 | 0.5 |
Echinococcus granulosus | L aminoadipate semialdehyde | 0.01 | 0.0141 | 0.0141 |
Schistosoma mansoni | bromodomain-containing protein 3 brd3 | 0.0883 | 1 | 1 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0119 | 0.0379 | 0.0379 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0119 | 0.0379 | 0.0379 |
Echinococcus multilocularis | Bromodomain containing protein | 0.0393 | 0.3833 | 0.3833 |
Trichomonas vaginalis | bromodomain containing protein, putative | 0.0548 | 0.5783 | 0.3163 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0215 | 0.159 | 0.159 |
Brugia malayi | Bromodomain containing protein | 0.0883 | 1 | 1 |
Trypanosoma brucei | cytochrome P450, putative | 0.0119 | 0.0379 | 0.5 |
Trichomonas vaginalis | bromodomain-containing protein, putative | 0.0883 | 1 | 1 |
Schistosoma mansoni | camp-specific 35-cyclic phosphodiesterase | 0.0102 | 0.0156 | 0.0014 |
Echinococcus multilocularis | L aminoadipate semialdehyde | 0.01 | 0.0141 | 0.0141 |
Trichomonas vaginalis | bromodomain-containing protein, putative | 0.0883 | 1 | 1 |
Entamoeba histolytica | bromodomain-containing protein | 0.0393 | 0.3833 | 0.5 |
Trypanosoma cruzi | cytochrome P450, putative | 0.0119 | 0.0379 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.01 | 0.0141 | 0.0141 |
Echinococcus multilocularis | cAMP specific 3',5' cyclic phosphodiesterase | 0.0102 | 0.0156 | 0.0156 |
Trichomonas vaginalis | bromodomain-containing protein, putative | 0.0548 | 0.5783 | 0.3163 |
Trichomonas vaginalis | bromodomain-containing protein, putative | 0.0548 | 0.5783 | 0.3163 |
Brugia malayi | hypothetical protein | 0.0335 | 0.3093 | 0.3093 |
Brugia malayi | Cytochrome P450 family protein | 0.0119 | 0.0379 | 0.0379 |
Brugia malayi | Cytochrome P450 family protein | 0.0119 | 0.0379 | 0.0379 |
Echinococcus granulosus | cAMP specific 3'5' cyclic phosphodiesterase | 0.0102 | 0.0156 | 0.0156 |
Echinococcus multilocularis | cAMP specific 3',5' cyclic phosphodiesterase | 0.0102 | 0.0156 | 0.0156 |
Loa Loa (eye worm) | CYP4Cod1 | 0.0119 | 0.0379 | 0.0379 |
Onchocerca volvulus | 0.0393 | 0.3833 | 1 | |
Brugia malayi | Cytochrome P450 family protein | 0.0215 | 0.159 | 0.159 |
Entamoeba histolytica | bromodomain-containing protein | 0.0393 | 0.3833 | 0.5 |
Giardia lamblia | Kinase, putative | 0.0393 | 0.3833 | 1 |
Echinococcus granulosus | bromodomain containing 2 | 0.0883 | 1 | 1 |
Entamoeba histolytica | bromodomain-containing protein | 0.0393 | 0.3833 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0102 | 0.0156 | 0.0156 |
Brugia malayi | aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase | 0.01 | 0.0141 | 0.0141 |
Leishmania major | cytochrome p450-like protein | 0.0119 | 0.0379 | 0.5 |
Mycobacterium ulcerans | cytochrome P450 185A4 Cyp185A4 | 0.0119 | 0.0379 | 0.5 |
Loa Loa (eye worm) | bromodomain containing protein | 0.0393 | 0.3833 | 0.3833 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0548 | 0.5783 | 0.3163 |
Trichomonas vaginalis | bromodomain-containing protein, putative | 0.0548 | 0.5783 | 0.3163 |
Echinococcus granulosus | cAMP specific 3'5' cyclic phosphodiesterase | 0.0102 | 0.0156 | 0.0156 |
Toxoplasma gondii | bromodomain-containing protein | 0.0393 | 0.3833 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.049 | 0.5044 | 0.1964 |
Echinococcus multilocularis | bromodomain containing 2 | 0.0883 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (functional) | > 53 uM | PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS hits for small molecule agonists of the CRF-binding protein and CRF-R2 receptor complex. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 17.7828 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 18.526 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 35.4813 um | PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 50.1187 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.